Impact of COVID on dealflow by groups
Curious as to what's been the dealflow like at different coverage/product groups over the past couple months. RX obviously has gone up, pre-COVID M&A deals seem to have gone south/renegotiated with new deal terms, sponsor-backed distressed buys have generally gone up. What are other trends people are seeing rn?
Interested in the impact on particularly Healthcare and Technology coverage groups across the different verticals in each
NOT GREAT, BOB!
Both DCM & ECM are up http://graphics.wsj.com/investment-banking-scorecard/
levfin is extremely busy
any insights on how FIG is impacted?
Seeing m&a pick up a ton over the last month. Looking like a jam packed 2H2020
what coverage?
Industrials and consumer
How does DCM look?
https://markets.ft.com/data/league-tables/tables-and-trends/Bonds
How about Industrials?
any insight on consumer or healthcare
Consequatur tenetur amet unde sed sed qui consequatur. Aut omnis ipsam molestiae sed omnis similique sint. Deleniti sequi ipsam rerum occaecati quae minus totam. Et sit tempore beatae sint expedita.
See All Comments - 100% Free
WSO depends on everyone being able to pitch in when they know something. Unlock with your email and get bonus: 6 financial modeling lessons free ($199 value)
or Unlock with your social account...